Reference health

Prophylactic Anticoagulation and Thrombosis in Hospitalized Patients with Clinically Stable COVID-19 at Admission: From the CLOT-COVID Study

https://doi.org/10.2139/ssrn.4098894
CiteStamped reference-health badge
21/21 checkable references clean · checked 2026-07-23

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

5 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 21 checked references that resolve
resolves10.1056/NEJMoa2002032
Clinical Characteristics of Coronavirus Disease 2019 in China
resolves10.1016/S0140-6736(20)30183-5
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
resolves10.1001/jama.2020.13372
Thrombosis in Hospitalized Patients With COVID-19 in a New York City Health System
resolves10.1016/j.thromres.2020.04.041
Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis
resolves10.1111/jth.14810
ISTH interim guidance on recognition and management of coagulopathy in COVID‐19
resolves10.1182/bloodadvances.2020003763
American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19
resolves10.1016/j.jacc.2020.04.031
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
resolves10.1016/j.jacc.2021.12.023
Anticoagulation in Patients With COVID-19
resolves10.1055/a-1366-9656
Prevalence and Predictors of Venous Thromboembolism or Mortality in Hospitalized COVID-19 Patients
resolves10.1253/circj.CJ-21-0169
Incidence and Clinical Features of Venous Thromboembolism in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) in Japan
resolves10.1001/jama.2021.4152
Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit
resolves10.1016/S0140-6736(21)01203-4
Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial
resolves10.1056/NEJMoa2105911
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19
resolves10.1001/jama.2021.17272
Effect of Antithrombotic Therapy on Clinical Outcomes in Outpatients With Clinically Stable Symptomatic COVID-19
resolves10.1016/j.thromres.2022.03.023
Influence of sex on development of thrombosis in patients with COVID-19: From the CLOT-COVID study
resolves10.3400/avd.ra.20-00145
The Primary Prevention of Venous Thromboembolism in Patients with COVID-19 in Japan: Current Status and Future Perspective
resolves10.1161/CIR.0b013e31826e1058
Third Universal Definition of Myocardial Infarction
resolves10.7326/M20-2003
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19
resolves10.1016/j.jacc.2020.08.070
Registry of Arterial and Venous Thromboembolic Complications in Patients With COVID-19
resolves10.1016/j.jacc.2020.08.041
Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients With COVID-19
resolves10.1016/S0140-6736(21)01755-4
1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study
The 5 references without a DOI — listed, not checked
no DOI — not checkedTherapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19
no DOI — not checkedThe current status of thrombosis and anticoagulation therapy in patients with COVID-19 in Japan: From the CLOT-COVID study
no DOI — not checkedDefinition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients
no DOI — not checkedProposal of the Definition for COVID-19-Associated Coagulopathy
no DOI — not checkedEarly initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: cohort study
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.2139/ssrn.4098894"><img src="https://citestamp.com/citestamped/10.2139/ssrn.4098894/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.2139/ssrn.4098894/badge.svg)](https://citestamp.com/citestamped/10.2139/ssrn.4098894)